XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (5,547,609) $ (7,298,869) $ (11,298,558) $ (10,500,358)
Adjustments to reconcile net loss with cash flows from operations:        
Depreciation and amortization expense 624,419 600,978 1,250,542 790,367
Stock-based compensation 2,261,126 629,993 823,564 1,246,019
Extinguishment of note payable 985,481 985,842
Warrant exercise inducement expense 366,795 366,795
Impairment loss/write-off of assets     1,333,566 1,671,804
Amortization of debt discounts and issuance costs 237,435 214,668 451,749 109,764
Stock issued for services     41,071
Impairment losses 1,059,495    
Forgiveness of note payable (485,760)    
Changes in operating assets and liabilities:        
Accounts receivable (127,930) (23,217) 45,319 (5,770)
Net investment in direct financing lease 35,371 31,796 65,333 58,727
Other current assets and other assets (308,479) 21,984 409,290 (50,647)
Decrease in other assets     37,526
Inventory 113,870 374,366 (109,213) (18,834)
Accounts payable and accrued expenses 644,649 1,056,433 1,157,370 413,773
Contract liabilities     (187,586) 189,006
Deferred revenue 223,393 28,810    
Other liabilities (47,809)    
Net cash flows from operating activities (2,377,324) (1,951,287) (4,668,461) (6,055,078)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of property and equipment (78,325) (2,394) (27,364)
Investment in other assets including work in progress (10,829) (124,870) (299,436) (1,604,152)
Other assets 13,462    
Net cash flows from investing activities (89,154) (113,802) (299,436) (1,631,516)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from issuance of convertible note payable 1,510,000 1,510,000 408,000
Payment of debt issuance costs (104,800) (104,800)
Proceeds from sale of common stock offering, net of offering costs     5,076,455 2,928,312
Common stock repurchase     (1)  
Proceeds from the exercise of warrants     1,248,983
Proceeds from the paycheck protection program     485,760
Principal payments on capital lease obligations and notes payable     (40,157) (31,188)
Proceeds from sale of common stock, 200,000    
Proceeds from exercise of warrants 283,950    
Proceeds from payroll protection loan 485,760 485,760    
Payments on notes payable (2,892)    
Principal payments on capital lease obligation (19,224) (19,487)    
Net cash flows from financing activities 463,644 2,355,423 8,176,240 3,305,124
Effect of Foreign Currencies 42,971 (42,465) (10,147) (23,780)
Net Change in Cash (1,959,863) 247,869 3,198,196 (4,405,250)
Cash, Beginning of the Period 3,765,277 567,081 567,081 4,972,331
Cash, End of the Period 1,805,414 814,950 3,765,277 567,081
Supplemental Disclosure of Cash Flow Information:        
Cash paid for interest 8,779 5,296 9,488 10,771
Cash paid for income taxes 9,853 12,466 36,323 62,931
Modification of warrants issued with convertible debt 95,223 95,223
Exchange of notes payable and accrued interest for convertible notes payable 2,662,000 2,662,000
Settlement of accounts payable with common stock     8,270
Purchase of vehicle with note payable     16,510
Recognition of lease right to use asset and liabilities     514,473
Reclass from other current assets to other assets     106,446  
Cashless option and warrant exercises     168  
Reclassification of software development to intangible costs     $ 128,005 $ 3,111,668
Warrant exercise with a subscription receivable 965,033    
Settlement of accounts payable with issuance of common stock 8,270    
Conversion of convertible notes payable and accrued interest to common stock 6,232,340    
Settlement of accounts payable with issuance of stock options $ 349,376